🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07259356
Enrolling by invitation Not applicable

Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia

NCT07259356 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2024-08-01
Last updated
2025-12-02

Condition(s) studied

Hemophilia

Investigational drug(s) / intervention(s)

ControlBFR Exercise (50% of the LOP) while Leg Press Exercise (4 Sets, All out)

Control: Sham-BFR Exercise (20mmHg) while Leg Press Exercise (4 Sets, All out)

BFR Exercise (50% of the LOP) while Leg Press Exercise (4 Sets, All out): BFR Exercise (50% of the LOP) while Leg Press Exercise (4 Sets, All out)

Study summary

In the course of a cross-over study design, 12 patients with hemophilic arthropathy will perform a training load on the knee extensor muscles. The subjects will each perform one intervention with blood flow restriction and one with a Sham-BFR intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients with haemophilia * Ability for an exercise intervention Exclusion Criteria: * Sickle Cell Anemia * Intravascular stents/bypasses * Open Wounds/Infections of the lower extremity

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Bonn Bonn North Rhine-Westphalia

More University Hospital, Bonn trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07259356 on ClinicalTrials.gov ↗ ← All trials in Germany